The German subsidiary of Zurich Insurance Group, Zurich Group Germany, has wholly acquired dental technology platform Dentolo, with venture investors Yabeo Capital, Atlantic Labs and IBB Beteiligungsgesellschaft selling their stakes in the company.
Backers close a $18.6m round started in 2015 with an initial $10.6m capital injection
GP invests via its Nordic Capital Fund IX, which held a final close on €4.3bn in May 2018
Abalos Therapeutics is a biotechnology company focused on developing immuno-oncology therapeutics
Existing management team will lead the company's future growth and development